This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bevers, E. Articles by Zwaal, R. Search for Related Content PubMed PubMed Citation Articles by Bevers, E. Articles by Zwaal, R. Social Bookmarking                         What's this?

Review : Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling

Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands

P. Comfurius

Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands

Dwc Dekkers

Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands

M. Harmsma

Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands

Rfa Zwaal

Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands

The various phospholipid classes that comprise mammalian cell membranes are distributed over both leaflets of the bilayer in a non-random fashion. While a specific and ATP-dependent transporter is responsible for rapid inward movement of aminophospholipids, its inhibition does not lead to spontaneous redistribution of lipids. Conditions of cellular activation which are accompanied with increased levels of intracellular Ca²⁺ may cause a collapse of lipid asymmetry by switching on an ATP-independently operating scramblase, which accelerates bidirectional movement of all phospholipid classes. The most prominent change in transmembrane lipid distribution is surface exposure of phosphatidylserine (PS), the more so since conditions which activate scramblase in most if not all cases lead to inhibition of aminophospholipid translocase activity, which will prevent PS from being pumped back to the inner leaflet of the membrane. Surface-exposed PS serves at least two important physiological functions: it promotes blood coagulation and offers a recognition signal for clearance by macrophages and other cells of the reticuloendothelial system. As such, PS exposure may form an important early event in the process of apoptosis to ensure rapid removal of these cells in order to avoid release of their inflammatory contents. Defective regulation of transbilayer lipid distribution may result in clinical manifestations such as in the Scott syndrome, a bleeding disorder caused by an impaired scramblase activity. Conversely, excessive PS exposure may lead to thrombosis or may explain formation of so-called antiphospholipid antibodies as occurring in patients with antiphospholipid syndrome.

Key Words: lipid-asymmetry • aminophospholipid-translocase • scramblase • phosphatidylserine • coagulation • apoptosis • cell-recognition • Scott-syndrome • antiphospholipid-syndrome

Lupus, Vol. 7, No. 2 suppl, S126-S131 (1998)
DOI: 10.1177/096120339800700228


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Hu and J. W. Kronstad A Putative P-Type ATPase, Apt1, Is Involved in Stress Tolerance and Virulence in Cryptococcus neoformans Eukaryot. Cell, January 1, 2010; 9(1): 74 - 83. [Abstract] [Full Text] [PDF]

				K. Balasubramanian, B. Mirnikjoo, and A. J. Schroit Regulated Externalization of Phosphatidylserine at the Cell Surface: IMPLICATIONS FOR APOPTOSIS J. Biol. Chem., June 22, 2007; 282(25): 18357 - 18364. [Abstract] [Full Text] [PDF]

				E Toubi, A Kessel, I Rosner, M Rozenbaum, M Lorber, D Paran, E Sabo, and T D Golan Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin antibody production in SLE Lupus, April 1, 2003; 12(4): 297 - 301. [Abstract] [PDF]